Terms: = Breast cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Treatment
85 results:
1. Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
Steadman JA; Glasgow AE; Neequaye NN; Habermann EB; Hieken TJ
J Surg Oncol; 2024 May; 129(6):1041-1050. PubMed ID: 38436625
[TBL] [Abstract] [Full Text] [Related]
2. The Association Between Mammography Screening Frequency and breast cancer treatment and Outcomes: A Retrospective Cohort Study.
Liu Y; Gordon AS; Eleff M; Barron JJ; Chi WC
J Breast Imaging; 2023 Feb; 5(1):21-29. PubMed ID: 38416960
[TBL] [Abstract] [Full Text] [Related]
3. Decision aids for people facing health treatment or screening decisions.
Stacey D; Lewis KB; Smith M; Carley M; Volk R; Douglas EE; Pacheco-Brousseau L; Finderup J; Gunderson J; Barry MJ; Bennett CL; Bravo P; Steffensen K; Gogovor A; Graham ID; Kelly SE; Légaré F; Sondergaard H; Thomson R; Trenaman L; Trevena L
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD001431. PubMed ID: 38284415
[TBL] [Abstract] [Full Text] [Related]
4. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
Javadi M; Sazegar H; Doosti A
BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
[TBL] [Abstract] [Full Text] [Related]
5. Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for breast cancer: A Randomized Controlled Trial From the Setouchi breast Project-10.
Iwamoto T; Kajiwara Y; Kawada K; Takabatake D; Miyoshi Y; Kubo S; Suzuki Y; Yamamoto M; Ogasawara Y; Hatono M; Yoshitomi S; Hara K; Sasahara A; Ohsumi S; Ikeda M; Doihara H; Mizota Y; Yamamoto S; Taira N
Clin Breast Cancer; 2024 Jan; 24(1):27-35.e8. PubMed ID: 37852895
[TBL] [Abstract] [Full Text] [Related]
6. Perioperative genetic testing and time to surgery in patients with breast cancer.
Wu V; Chichura AM; Dickard J; Turner C; Al-Hilli Z
Surgery; 2024 Mar; 175(3):712-717. PubMed ID: 37848355
[TBL] [Abstract] [Full Text] [Related]
7. Conservative re-treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: We can hope, at least.
Raffone A; Raimondo D; Rovero G; Travaglino A; Lopez G; Di Maio CM; Neola D; Raspollini A; Renzulli F; Filippelli A; Casadio P; Seracchioli R; Guida M
Int J Gynaecol Obstet; 2024 May; 165(2):542-551. PubMed ID: 37772342
[TBL] [Abstract] [Full Text] [Related]
8. Differences in total cognition and cerebrovascular function in female breast cancer survivors and cancer-free women.
Downs TL; Whiteside EJ; Foot G; Mills DE; Bliss ES
Breast; 2023 Jun; 69():358-365. PubMed ID: 37018967
[TBL] [Abstract] [Full Text] [Related]
9. Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic breast cancer in the Netherlands.
Luyendijk M; Blommestein H; Uyl-de Groot C; Siesling S; Jager A
JAMA Netw Open; 2023 Feb; 6(2):e2256170. PubMed ID: 36795415
[TBL] [Abstract] [Full Text] [Related]
10. Patient reported improvement in sexual health outcomes following care in a sexual health clinic for women with cancer.
Rash JK; Seaborne LA; Peterson M; Kushner DM; Sobecki JN
Support Care Cancer; 2023 Feb; 31(3):171. PubMed ID: 36795172
[TBL] [Abstract] [Full Text] [Related]
11. A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for breast cancer Patients Using a Population-Based Electronic Medical Record System.
Wu G; Cheligeer C; Brisson AM; Quan ML; Cheung WY; Brenner D; Lupichuk S; Teman C; Basmadjian RB; Popwich B; Xu Y
Ann Surg Oncol; 2023 Apr; 30(4):2095-2103. PubMed ID: 36542249
[TBL] [Abstract] [Full Text] [Related]
12. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L; Poggio F; Blondeaux E; De Placido S; Giuliano M; Forestieri V; De Laurentiis M; Gravina A; Bisagni G; Rimanti A; Turletti A; Nisticò C; Vaccaro A; Cognetti F; Fabi A; Gasparro S; Garrone O; Alicicco MG; Urracci Y; Mansutti M; Poletti P; Correale P; Bighin C; Puglisi F; Montemurro F; Colantuoni G; Lambertini M; Boni L;
Lancet Oncol; 2022 Dec; 23(12):1571-1582. PubMed ID: 36370716
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Utility of Universal Germline Genetic Testing for Patients With breast cancer.
Whitworth PW; Beitsch PD; Patel R; Rosen B; Compagnoni G; Baron PL; Simmons R; Brown EA; Gold L; Holmes D; Smith LA; Kinney M; Grady I; Clark P; Barbosa K; Lyons S; Riley L; Coomer C; Curcio L; Ruiz A; Khan S; MacDonald H; Hughes K; Hardwick MK; Heald B; Munro SB; Nielsen SM; Esplin ED
JAMA Netw Open; 2022 Sep; 5(9):e2232787. PubMed ID: 36136330
[TBL] [Abstract] [Full Text] [Related]
14. Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer.
Song YQ; Hong J; Wang JY; Peng J; Han JH; Luo HL
Cancer Radiother; 2023 Feb; 27(1):11-16. PubMed ID: 35879144
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese breast cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract] [Full Text] [Related]
16. Phase III study of the European Organisation for Research and treatment of cancer Quality of Life cancer survivorship core questionnaire.
van Leeuwen M; Kieffer JM; Young TE; Annunziata MA; Arndt V; Arraras JI; Autran D; Hani HB; Chakrabarti M; Chinot O; Cho J; da Costa Vieira RA; Darlington AS; Debruyne PR; Dirven L; Doege D; Eller Y; Eichler M; Fridriksdottir N; Gioulbasanis I; Hammerlid E; van Hemelrijck M; Hermann S; Husson O; Jefford M; Johansen C; Kjaer TK; Kontogianni M; Lagergren P; Lidington E; Lisy K; Morag O; Nordin A; Al Omari ASH; Pace A; De Padova S; Petranovia D; Pinto M; Ramage J; Rammant E; Reijneveld J; Serpentini S; Sodergren S; Vassiliou V; Leeuw IV; Vistad I; Young T; Aaronson NK; van de Poll-Franse LV;
J Cancer Surviv; 2023 Aug; 17(4):1111-1130. PubMed ID: 35088246
[TBL] [Abstract] [Full Text] [Related]
17. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
Deuning-Smit E; Custers JAE; Miroševič Š; Takes RP; Jansen F; Langendijk JA; Terhaard CHJ; Baatenburg de Jong RJ; Leemans CR; Smit JH; Kwakkenbos L; Verdonck-de Leeuw IM; Prins JB
Head Neck; 2022 Apr; 44(4):914-925. PubMed ID: 35084079
[TBL] [Abstract] [Full Text] [Related]
18. Development and Validation of a Predictive Model of Severe Fatigue After breast cancer Diagnosis: Toward a Personalized Framework in Survivorship Care.
Di Meglio A; Havas J; Soldato D; Presti D; Martin E; Pistilli B; Menvielle G; Dumas A; Charles C; Everhard S; Martin AL; Coutant C; Tarpin C; Vanlemmens L; Levy C; Rigal O; Delaloge S; Lin NU; Ganz PA; Partridge AH; André F; Michiels S; Vaz-Luis I
J Clin Oncol; 2022 Apr; 40(10):1111-1123. PubMed ID: 35061509
[TBL] [Abstract] [Full Text] [Related]
19. Association of postoperative infection and oncological outcome after breast cancer surgery.
Adwall L; Pantiora E; Hultin H; Norlén O
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34240113
[TBL] [Abstract] [Full Text] [Related]
20. [Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after breast cancer].
Noeres D; Sperlich S; Röbbel L; Safieddine B; Deuker JU; Hillemanns P; Ismaéel F; Moser A; Noeding KH; Noesselt T; Pape J; Park-Simon TW; Peschel S; Seifert W; Siggelkow W; Thoma M; Uleer C; Geyer S
Rehabilitation (Stuttg); 2021 Apr; 60(2):86-94. PubMed ID: 33858017
[TBL] [Abstract] [Full Text] [Related]
[Next]
